Evidence map›Paper›PMID 40201322›Full record

ArticleFrontiers in medicine2025

Efficacy and safety of Jinghua Weikang capsule combined with amoxicillin-furazolidone triple/quadruple therapies in the rescue treatment of

Yao Yang, Xin Deng, Hui-Xia Xiao, Su-Man Ye, Zi-Cheng Wang, Feng Jiang, Hai-Xiao Han, Zai-Jian Wang, Ji-Zheng Ma, Yu Lan and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yao Yang *Department of Integrated Traditional Chinese and Western Medicine, Peking University First Hospital, Beijing, China.
Xin Deng *Kunming Traditional Chinese Medicine Hospital, Kunming, China.
Hui-Xia XiaoTaikang Xianlin Drum Tower Hosipital, Kunming, China.
Su-Man YeBeijing University of Chinese Medicine, Beijing, China.
Zi-Cheng WangBeijing University of Chinese Medicine, Beijing, China.
Feng JiangDongzhimen Hosipital Beijing University of Chinese Medicine, Beijing, China.
Hai-Xiao HanOriental Hospital of Beijing University of Chinese Medicine, Beijing, China.
Zai-Jian WangBeijing University of Chinese Medicine Third Affiliated Hospital, Beijing, China.
Ji-Zheng MaGuang'anmen Hospital, China Academy of Traditional Chinese Medicine, Beijing, China.
Yu LanBeijing Jishuitan Hospital, Beijing, China.
Hui YeDepartment of Integrated Traditional Chinese and Western Medicine, Peking University First Hospital, Beijing, China.
Xue-Zhi ZhangDepartment of Integrated Traditional Chinese and Western Medicine, Peking University First Hospital, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aim: To evaluate the efficacy and safety of Jinghua Weikang Capsule (JWC) combined with amoxicillin-furazolidone triple/quadruple therapies in the rescue treatment of drug-resistant Methods: Patients who failed Results: Four hundred eighty-eight patients were included in this study. The intention-to-treat (ITT) eradication rates in the four groups were 85.2, 73.8, 78.7 and 75.4% ( Conclusion: The eradication rate of the JWC-containing regimen demonstrated no statistically significant difference compared with bismuth-containing quadruple therapy in the rescue treatment of Clinical trial: https://clinicaltrials.gov/, identifier ChiCTR1800019326.

Indexed as

bismuth-containing quadruple therapyHelicobacter pyloriJinghua Weikang capsulemulti-center randomized controlled studyrescue treatment

Identifiers

PMID40201322
PMCPMC11975852

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.